Literature DB >> 21521764

Mechanisms underlying a life-threatening skeletal muscle Na+ channel disorder.

Dina Simkin1, Isabelle Léna, Pierre Landrieu, Laurence Lion-François, Damien Sternberg, Bertrand Fontaine, Saïd Bendahhou.   

Abstract

Myotonia is an intrinsic muscular disorder caused by muscle fibre hyperexcitability, which produces a prolonged time for relaxation after voluntary muscle contraction or internal mechanical stimulation. Missense mutations in skeletal muscle genes encoding Cl− or Na+ channels cause non-dystrophic myotonias.Mutations of the SCN4A gene that encodes the skeletal voltage-gated Na+ channel Nav1.4 can produce opposing phenotypes leading to hyperexcitable or inexcitable muscle fibres. Nav1.4 mutations result in different forms of myotonias that can be found in adults. However, the recently reported myotonic manifestations in infants have been shown to be lethal. This was typically the case for children suffering from severe neonatal episodic laryngospasm (SNEL). A novel Nav1.4 channel missense mutation was found in these children that has not yet been analysed. In this study, we characterize the functional consequences of the new A799S Na+ channel mutation that is associated with sodium channel myotonia in newborn babies. We have used mammalian cell expression and patch-clamp techniques to monitor the channel properties.We found that the A799S substitution changes several biophysical properties of the channel by causing a hyperpolarizing shift of the steady-state activation, and slowing the kinetics of fast inactivation and deactivation. In addition, the single channel open probability was dramatically increased, contributing hence to a severe phenotype. We showed that substitutions at position 799 of the Nav1.4 channel favoured the channel open state with sustained activity leading to hyperexcitability of laryngeal muscles that could be lethal during infancy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21521764      PMCID: PMC3145928          DOI: 10.1113/jphysiol.2011.207977

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  35 in total

1.  Hyperkalemic periodic paralysis and paramyotonia congenita--a novel sodium channel mutation.

Authors:  S Okuda; F Kanda; K Nishimoto; R Sasaki; K Chihara
Journal:  J Neurol       Date:  2001-11       Impact factor: 4.849

Review 2.  Skeletal muscle channelopathies: nondystrophic myotonias and periodic paralysis.

Authors:  Dipa L Raja Rayan; Michael G Hanna
Journal:  Curr Opin Neurol       Date:  2010-10       Impact factor: 5.710

3.  Immunoaffinity isolation of Na+ channels from rat skeletal muscle. Analysis of subunits.

Authors:  J M Casadei; R D Gordon; R L Barchi
Journal:  J Biol Chem       Date:  1986-03-25       Impact factor: 5.157

4.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

5.  Sodium channel inactivation defects are associated with acetazolamide-exacerbated hypokalemic periodic paralysis.

Authors:  S Bendahhou; T R Cummins; R C Griggs; Y H Fu; L J Ptácek
Journal:  Ann Neurol       Date:  2001-09       Impact factor: 10.422

6.  Primary structure of Electrophorus electricus sodium channel deduced from cDNA sequence.

Authors:  M Noda; S Shimizu; T Tanabe; T Takai; T Kayano; T Ikeda; H Takahashi; H Nakayama; Y Kanaoka; N Minamino
Journal:  Nature       Date:  1984 Nov 8-14       Impact factor: 49.962

7.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

8.  Myasthenic syndrome caused by mutation of the SCN4A sodium channel.

Authors:  Akira Tsujino; Chantal Maertens; Kinji Ohno; Xin-Ming Shen; Taku Fukuda; C Michael Harper; Stephen C Cannon; Andrew G Engel
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-23       Impact factor: 11.205

9.  Functional characterization and cold sensitivity of T1313A, a new mutation of the skeletal muscle sodium channel causing paramyotonia congenita in humans.

Authors:  Magali Bouhours; Damien Sternberg; Claire-Sophie Davoine; Xavier Ferrer; Jean Claude Willer; Bertrand Fontaine; Nacira Tabti
Journal:  J Physiol       Date:  2003-11-14       Impact factor: 5.182

10.  A new mutation in a family with cold-aggravated myotonia disrupts Na(+) channel inactivation.

Authors:  F F Wu; M P Takahashi; E Pegoraro; C Angelini; P Colleselli; S C Cannon; E P Hoffman
Journal:  Neurology       Date:  2001-04-10       Impact factor: 9.910

View more
  6 in total

1.  Keeping hyperactive voltage-gated sodium channels in silent mode.

Authors:  Saïd Bendahhou
Journal:  J Physiol       Date:  2012-06-01       Impact factor: 5.182

Review 2.  Mutational consequences of aberrant ion channels in neurological disorders.

Authors:  Dhiraj Kumar; Rashmi K Ambasta; Pravir Kumar
Journal:  J Membr Biol       Date:  2014-08-14       Impact factor: 1.843

Review 3.  Novel insights into the pathomechanisms of skeletal muscle channelopathies.

Authors:  James A Burge; Michael G Hanna
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

4.  Skeletal muscle na channel disorders.

Authors:  Dina Simkin; Saïd Bendahhou
Journal:  Front Pharmacol       Date:  2011-10-14       Impact factor: 5.810

5.  A recessive Nav1.4 mutation underlies congenital myasthenic syndrome with periodic paralysis.

Authors:  Karima Habbout; Hugo Poulin; François Rivier; Serena Giuliano; Damien Sternberg; Bertrand Fontaine; Bruno Eymard; Raul Juntas Morales; Bernard Echenne; Louise King; Michael G Hanna; Roope Männikkö; Mohamed Chahine; Sophie Nicole; Said Bendahhou
Journal:  Neurology       Date:  2015-12-11       Impact factor: 9.910

6.  Myotonia permanens with Nav1.4-G1306E displays varied phenotypes during course of life.

Authors:  Frank Lehmann-Horn; Adele D'Amico; Enrico Bertini; Mauro Lomonaco; Luciano Merlini; Kevin R Nelson; Heike Philippi; Gabriele Siciliano; Frank Spaans; Karin Jurkat-Rott
Journal:  Acta Myol       Date:  2017-09-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.